A case of pulmonary toxicity associated with G-CSF and doxorubicin administration

被引:15
作者
Eisenbeis, CF
Winn, D
Poelman, S
Polsky, CV
Rubenstein, JH
Olopade, OI
机构
[1] Univ Chicago, Med Ctr, Hematol Oncol Sect, Chicago, IL 60637 USA
[2] Univ Chicago, Med Ctr, Dept Med, Chicago, IL 60637 USA
关键词
G-CSF; doxorubicin; toxicity; pneumonitis;
D O I
10.1007/s002770000232
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The cytokine growth factor, G-CSF (granulocyte colony-stimulating factor), is commonly used in oncologic practice and is generally believed to be a safe agent to administer. We describe here a case of pulmonary toxicity associated with the concurrent administration of G-CSF and doxorubicin. We contend that G-CSF contributed to the life-threatening lung injury in our patient, and discuss additional reports in the literature of pulmonary toxicity associated with the use of this agent.
引用
收藏
页码:121 / 123
页数:3
相关论文
共 22 条
[1]   Anaphylactoid reaction in a normal donor given granulocyte colony-stimulating factor [J].
Adkins, DR .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) :812-813
[2]   POSSIBLE TOXICITY WITH THE ASSOCIATION OF G-CSF AND BLEOMYCIN [J].
BASTION, Y ;
REYES, F ;
BOSLY, A ;
GISSELBRECHT, C ;
YVER, A ;
GILLES, E ;
MARAL, J ;
COIFFIER, B .
LANCET, 1994, 343 (8907) :1221-1222
[3]   Anaphylactic reaction after a first filgrastim (granulocyte-colony stimulating factor) injection [J].
BatelCopel, L ;
MommejaMarin, H ;
Oudard, S ;
Chauvenet, L ;
PujadeLauraine, E ;
Coupier, J ;
Bernadou, A .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (13-14) :2428-2428
[4]  
BOOGAERTS MA, 1993, BLOOD, V82, pA495
[5]  
BROWN SL, 1991, NEW ENGL J MED, V325, P587
[6]  
CLEE MD, 1983, BRIT J DIS CHEST, V77, P227
[7]   Interstitial pneumonitis related to granulocyte colony-stimulating factor administration following chemotherapy for elderly patients with non-Hodgkin's lymphoma [J].
Hasegawa, Y ;
Ninomiya, H ;
Kamoshita, M ;
Ohtani, K ;
Kobayashi, T ;
Kojima, H ;
Nagasawa, T ;
Abe, T .
INTERNAL MEDICINE, 1997, 36 (05) :360-364
[8]  
Hershey AE, 1999, CLIN CANCER RES, V5, P2653
[9]   CYTOTOXIC DRUG-INDUCED PNEUMONIA AND POSSIBLE AUGMENTATION BY G-CSF - CLINICAL ATTENTION [J].
IKI, S ;
YOSHINAGA, K ;
OHBAYASHI, Y ;
URABE, A .
ANNALS OF HEMATOLOGY, 1993, 66 (04) :217-218
[10]  
JAIYESIMI I, 1991, NEW ENGL J MED, V325, P587